Document is current
Any future updates will be listed below
-
Authors
Minen, Mia T.
Waire, Erin K.
Torous, John https://orcid.org/0000-0002-5362-7937
Fishman, Jessica
Lipton, Richard B.
Powers, Scott W.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (AT011875)
- License Information
-
More Information
Article History
Received: 9 August 2024
Revised: 4 November 2024
Accepted: 11 November 2024
First Online: 8 January 2025
Competing interests
: M.T. Minen contributed to developing intellectual property being used in this study that is co-owned by NYU and IRODY. If the research is successful, NYU and IRODY may benefit from the outcome. J. Torous has received research support from Otsuka and as an advisor to Precision Mental Wellness, both unrelated to this study. R.B. Lipton has received research support from the National Institutes of Health, the FDA, and the National Headache Foundation. He serves as consultant, advisory board member, or has received honoraria or research support from AbbVie/Allergan, Amgen, Biohaven, Dr. Reddy’s Laboratories (Promius), electroCore, Eli Lilly and Company, GlaxoSmithKline, Lilly, Lundbeck, Merck, Novartis, Pfizer, Teva, Vector, and Vedanta Research. He receives royalties from Wolff’s Headache, 8th edition (Oxford University Press, 2009) and Informa. He holds stock/options in Axon, Biohaven, Cooltech, and Mainistee. S.W. Powers provides scientific consulting to Theranica. E.K. Waire and J. Fishman report no competing interests.
